Market Tracker

07/25 6:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

167.04
Data as of Jul 25
 -0.44 / -0.26%
Today’s Change
100.89
Today|||52-Week Range
185.43
+25.70%
Year-to-Date

Today’s Trading

Previous close167.48
Today’s open166.64
Day’s range164.57 - 168.42
Volume1,176,719
Average volume (3 months)1,231,520
Market cap$33.0B
Dividend yield--
Data as of 4:00pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+62.64%
Earnings growth (next 5 years)+28.55%
Revenue growth (last year)+34.85%
P/E ratio101.9
Price/Sales17.19
Price/Book13.81

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.84-0.68%
VRTXVertex Pharmaceutica...-0.02-0.02%
PRGOPerrigo Company PLC-2.08-1.32%
MYLMylan Inc-0.16-0.31%
Data as of 4:02pm ET, 07/25/2014

Financials

Last reporting dateJuly 24, 2014
EPS forecast (this quarter)$1.11
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Treasurer &
Director
Leonard Bell
Chief Global Operations Officer &
Executive VP
Stephen P. Squinto
Corporate headquarters
Cheshire, Connecticut

Forecasts